13F HOLDINGS REPORT
B Group, Inc.
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001420506-26-000462
Total Value
$135.4M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ADMA BIOLOGICS INC | ADMA | 2,457,542 | $44.8M | 33.10% |
| 2 | CELLECTIS S A | CLLS | 3,281,501 | $15.9M | 11.73% |
| 3 | PALISADE BIO INC | PALI | 4,500,000 | $10.6M | 7.81% |
| 4 | TAYSHA GENE THERAPIES INC | TSHA | 1,800,556 | $9.9M | 7.31% |
| 5 | PRAXIS PRECISION MEDICINES I | PRAX | 33,237 | $9.8M | 7.23% |
| 6 | SIGHT SCIENCES INC | SGHT | 920,000 | $7.3M | 5.39% |
| 7 | ZAI LAB LTD | ZLAB | 400,000 | $7.1M | 5.21% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 90,000 | $6.3M | 4.62% |
| 9 | ASSEMBLY BIOSCIENCES INC | ASMB | 175,706 | $6.0M | 4.41% |
| 10 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,500,000 | $4.1M | 3.02% |
| 11 | SPYRE THERAPEUTICS INC | SYRE | 100,000 | $3.3M | 2.42% |
| 12 | AURA BIOSCIENCES INC | AURA | 572,576 | $3.1M | 2.30% |
| 13 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 135,000 | $3.1M | 2.29% |
| 14 | ORUKA THERAPEUTICS INC | ORKA | 75,000 | $2.3M | 1.68% |
| 15 | APOGEE THERAPEUTICS INC | APGE | 20,000 | $1.5M | 1.11% |
| 16 | REPLIMUNE GROUP INC | REPL | 50,000 | $486,000 | 0.36% |